These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3225640)

  • 1. Effect of lonidamine on human malignant gliomas: biochemical studies.
    Paggi MG; Carapella CM; Fanciulli M; Del Carlo C; Giorno S; Zupi G; Silvestrini B; Caputo A; Floridi A
    J Neurooncol; 1988 Nov; 6(3):203-9. PubMed ID: 3225640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lonidamine on the utilization of 14C-labeled glucose by human astrocytoma cells.
    Paggi MG; Zupi G; Fanciulli M; Del Carlo C; Giorno S; Laudonio N; Silvestrini B; Caputo A; Floridi A
    Exp Mol Pathol; 1987 Oct; 47(2):154-65. PubMed ID: 2820786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lonidamine on the aerobic glycolysis of normal and phytohemagglutinin-stimulated human peripheral blood lymphocytes.
    Nista A; De Martino C; Malorni W; Marcante ML; Silvestrini B; Floridi A
    Exp Mol Pathol; 1985 Apr; 42(2):194-205. PubMed ID: 3156759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of glycolysis in neuroepithelial tumors.
    Floridi A; Paggi MG; Fanciulli M
    J Neurosurg Sci; 1989; 33(1):55-64. PubMed ID: 2674359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells.
    Floridi A; Paggi MG; Marcante ML; Silvestrini B; Caputo A; De Martino C
    J Natl Cancer Inst; 1981 Mar; 66(3):497-9. PubMed ID: 6937706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells.
    Floridi A; Paggi MG; D'Atri S; De Martino C; Marcante ML; Silvestrini B; Caputo A
    Cancer Res; 1981 Nov; 41(11 Pt 1):4661-6. PubMed ID: 7306982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of the antineoplastic drug lonidamine: 31P and 13C nuclear magnetic resonance studies.
    Ben-Horin H; Tassini M; Vivi A; Navon G; Kaplan O
    Cancer Res; 1995 Jul; 55(13):2814-21. PubMed ID: 7796408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria-bound hexokinase as target for therapy of malignant gliomas.
    Oudard S; Poirson F; Miccoli L; Bourgeois Y; Vassault A; Poisson M; Magdelénat H; Dutrillaux B; Poupon MF
    Int J Cancer; 1995 Jul; 62(2):216-22. PubMed ID: 7622299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of action of the anti-neoplastic drug lonidamine on drug-sensitive and drug-resistant human breast cancer cells: 31P and 13C nuclear magnetic resonance studies.
    Vivi A; Tassini M; Ben-Horin H; Navon G; Kaplan O
    Breast Cancer Res Treat; 1997 Mar; 43(1):15-25. PubMed ID: 9065595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Energy metabolism of human LoVo colon carcinoma cells: correlation to drug resistance and influence of lonidamine.
    Fanciulli M; Bruno T; Giovannelli A; Gentile FP; Di Padova M; Rubiu O; Floridi A
    Clin Cancer Res; 2000 Apr; 6(4):1590-7. PubMed ID: 10778993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of aerobic glycolysis in normal and neoplastic lymphoid cells induced by Lonidamine [1-(2,4-dichlorobenzyl)-I-H-indazol-3-carboxylic acid].
    Natali PG; Salsano F; Viora M; Nista A; Malorni W; Marolla A; De Martino C
    Oncology; 1984; 41 Suppl 1():7-14. PubMed ID: 6609324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of lonidamine in the 9L brain tumor model involves inhibition of lactate efflux and intracellular acidification.
    Ben-Yoseph O; Lyons JC; Song CW; Ross BD
    J Neurooncol; 1998 Jan; 36(2):149-57. PubMed ID: 9525814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the antitumor drug lonidamine on glucose metabolism of adriamycin-sensitive and -resistant human breast cancer cells.
    Fanciulli M; Valentini A; Bruno T; Citro G; Zupi G; Floridi A
    Oncol Res; 1996; 8(3):111-20. PubMed ID: 8823807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energy metabolism of normal and lonidamine-treated Sertoli cells of rats.
    Floridi A; Marcante ML; D'Atri S; Feriozzi R; Menichini R; Citro G; Cioli V; De Martino C
    Exp Mol Pathol; 1983 Feb; 38(1):137-47. PubMed ID: 6832337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative effect of lonidamine on a human glioblastoma multiforme cell line.
    Iacopino F; Sica G; Macrì P; Paggi MG; Scerrati M; Roselli R; Marchetti P; Della Cuna GR; Marini L
    J Neurosurg Sci; 1990; 34(3-4):193-7. PubMed ID: 1965900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Lonidamine on murine and human tumor cells in vitro. A morphological and biochemical study.
    De Martino C; Battelli T; Paggi MG; Nista A; Marcante ML; D'Atri S; Malorni W; Gallo M; Floridi A
    Oncology; 1984; 41 Suppl 1():15-29. PubMed ID: 6717891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory action of the antitumor agent lonidamine on mitochondrial respiration of Trypanosoma cruzi and T. brucei.
    Turrens JF
    Mol Biochem Parasitol; 1986 Sep; 20(3):237-41. PubMed ID: 3531848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of doxorubicin content by the antitumor drug lonidamine in resistant Ehrlich ascites tumor cells through modulation of energy metabolism.
    Floridi A; Bruno T; Miccadei S; Fanciulli M; Federico A; Paggi MG
    Biochem Pharmacol; 1998 Oct; 56(7):841-9. PubMed ID: 9774146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the association of Gossypol and Lonidamine on the energy metabolism of Ehrlich ascites tumor cells.
    Floridi A; D'Atri S; Menichini R; Marcante ML; Nista A; Silvestrini B; Caputo A; De Martino C
    Exp Mol Pathol; 1983 Jun; 38(3):322-35. PubMed ID: 6852206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell membrane changes induced by lonidamine in human erythrocytes and T lymphocytes, and Ehrlich ascites tumor cells.
    De Martino C; Malorni W; Accinni L; Rosati F; Nista A; Formisano G; Silvestrini B; Arancia G
    Exp Mol Pathol; 1987 Feb; 46(1):15-30. PubMed ID: 3492392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.